Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

J. Vera, MD, C. Quintarelli, PhD, B. Savoldo, MD, G. Giordano, PhD, A. Foster, PhD, M. Pule, MD, Helen Heslop, MD, C. Rooney, PhD, Malcolm Brenner, MD, PhD, G. Dotti, MD

Blood (2006) 108 (11): 1721.

https://doi.org/10.1182/blood.V108.11.1721.1721

Published: 2006

Journal Articles

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Joseph C. Fratantoni, MD, Linhong Li, PhD, Linda N. Liu, PhD, Madhusudan V. Peshwa, PhD, Malcolm Brenner, MD, PhD, Eric Yvon, MS, George Carrum, MD, Ettore Biagi, MD

Blood (2005) 106 (11): 450.

https://doi.org/10.1182/blood.V106.11.450.450

Published: 2005

Journal Articles

Immunotherapy of Chronic Lymphocytic Leukemia using CD40L and IL2 Expressing Autologous Tumor Cells.

Ettore Biagi, MD, Uday Popat, MD, Rousseau Raphael, MD, Yvon Eric, MS, Dotti Giampietro, MD, Rice Lawrence, MD, Michael Andreef, MD, PhD, Malcolm Brenner, MD, PhD

Blood (2004) 104 (11): 768.

https://doi.org/10.1182/blood.V104.11.768.768

Published: 2004

Journal Articles

Molecular Transfer of Human CD40 and OX40 Ligands to Leukemic Human B-CLL Cells Extensively Expands Tumor-Reactive Cytotoxic T-Lymphocytes.

Ettore Biagi, MD, Giampietro Dotti, MD, Eric Yvon, MS, Raphael Rousseau, MD, Edward Lee, MD, Stephen Gotschalk, MD, PhD, Malcolm Brenner, MD, PhD

Blood (2004) 104 (11): 951.

https://doi.org/10.1182/blood.V104.11.951.951

Published: 2004

Journal Articles

High Incidence but Low Morbitiy of Early Cytomegalovirus (CMV) Infections Following Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation with Alemtuzumab and Ganciclovir Prophylaxis.

Renu Lamba, MD, George Carrum, MD, Robert Krance, MD, Helen Heslop, MD, Malcolm Brenner, MD, Uday Popat

Blood (2004) 104 (11): 5098.

https://doi.org/10.1182/blood.V104.11.5098.5098

Published: 2004

NARROW

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Immunotherapy of Chronic Lymphocytic Leukemia using CD40L and IL2 Expressing Autologous Tumor Cells.

Molecular Transfer of Human CD40 and OX40 Ligands to Leukemic Human B-CLL Cells Extensively Expands Tumor-Reactive Cytotoxic T-Lymphocytes.

High Incidence but Low Morbitiy of Early Cytomegalovirus (CMV) Infections Following Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation with Alemtuzumab and Ganciclovir Prophylaxis.

Email alerts

ASH Publications

American Society of Hematology

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Immunotherapy of Chronic Lymphocytic Leukemia using CD40L and IL2 Expressing Autologous Tumor Cells.

Molecular Transfer of Human CD40 and OX40 Ligands to Leukemic Human B-CLL Cells Extensively Expands Tumor-Reactive Cytotoxic T-Lymphocytes.

High Incidence but Low Morbitiy of Early Cytomegalovirus (CMV) Infections Following Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation with Alemtuzumab and Ganciclovir Prophylaxis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only